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Several dehydroabietane and sandaracopimarane derivatives, (1-4) isolated from leaves of Juniperus brevifolia,[1] an endemic conifer from Azores, 
displayed antiproliferative activity against cancer cell lines (HeLa, A-549 and MCF-7) and bactericidal effect against Bacillus cereus at different 
concentrations tested (Table 1).[1] 
INTRODUCTION: 
In this work, protein-ligand docking was performed, using the FlexScreen program, in order to pick molecular targets, from a large set of 
common anticancer (63) and antimicrobial (39) targets, for the selected compounds 1-4. 
Comp. 
HeLa MCF-7 A-549 Vero B. cereus 
Lag 
phase 
Log 
phase 
Lag 
phase 
Log 
phase 
Lag 
phase 
Log 
phase 
Lag 
phase 
Log 
phase 
MIC MBC 
1 15.7 25.9 31.7 40.4 23.6 44.4 28.0 54.5 2.5 – 5 10 – 20 
2 49.0 52.7 >60 >60 46.2 60.0 54.4 >60 - - 
3 46.5 52.1 58.5 >60 53.7 >60 >60 >60 20 20 – 40 
4 49.6 >60 >60 >60 >60 >60 nd nd - - 
Table 2: Preferred anticancer targets and 
interaction energies. 
RESULTS: 
  The compounds 1 and 3 interact preferentially with phosphatidylinositol-3,4,5-trisphosphate 5-
phosphatase 2, (SHIP2), a clinically relevant novel anticancer target. This enzyme has high 
therapeutic index given its over-expression in cancer and its dispensability for normal cell 
survival.[3]  
  The hydroxyl groups and their ability to form H-bond, seem to play a significant role in these 
interactions since the H atom interacts with the carbonyl group of the aspartate residue and the 
oxygen atom interact with H-N of Arginine residue (Fig 1a). 
The compound 4 interact preferentially with -tubulin (Fig 1b), the protein that makes up 
microtubules,  not only by its OH group (H-bond with serine and tyrosine residue), but also by 
its carbonyl group (H-bond between N-H group of the alanine residue and oxygen atom from 
carbonyl group). 
The correlation between experimental and calculated data for anticancer targeta show that the 
compounds probably inhibited the targets TNKS-1, CDK1 and HIF1A in the assay against cancer 
cell line Vero. Against cancer cells lines HeLa, MCF-7 and A-59, the compounds probably 
inhibited PPAR-. 
Fig 1. Representation of the obtained interactions between a) 
compound 1 and target SHIP2 and b) compound 4 and target 
TUBA. 
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Anticancer targets  
Antimicrobial targets  
 Compounds 1 and 3 interact, both by H-bond, preferentially with RNA polymerase (RNAP), an 
enzyme that in bacteria catalyzes the synthesis of mRNA and ncRNA.  
 The hydroxyl group of compound 3 interacts with carbonyl group of aspartate (ASP30) (Fig 2 
a). The hydroxyl groups of the compound 1 and 3, also interact with the carbonyl group of lysine 
residue (LYS27) (Fig 2b).  
Comp. 
Anticancer  target 
Target 
PDB 
code 
Energy (arbitrary units) 
Sample 1 Sample 2 
1 SHIP2 3RN8 -76,512 -76,156 
2 PDF 3G5K -86,313 -85,542 
3 SHIP2 3RN8 -76,983 -76,831 
4 TUBA Model -98,136 -97,943 
Comp.  
Antimicrobial target 
Target 
PDB 
Code 
Energy (arbitrary units) 
Sample 1 Sample 2 
1 RNAP 1EIK -230,447 -212,083 
3 RNAP 1EIK -234,812 -234,152 
1 PDF 2AIA -76,970 -76,476 
3 PDF 2AIA -75,318 -72,259 
The preferred targets for anticancer and 
antimicrobial compounds 1-4 and their interaction 
energies are shown in Tables 2 and 3. 
Table 1: Cytotoxic  (IC50 μM) and antimicrobial (μg/mL) activities of 
secondary metabolites from J. brevifolia leaves. 
Table 3: Preferred antimicrobial 
targets and interaction energies. 
The structural differences between the skeleton-
type dehydroabietane  and sandaracopimarane, 
do not seem to be relevant in the interaction 
with the targets 
Fig 2. Representation of the obtained interactions between 
compound 3 and target RNAP a) interactions with ASP30, b) 
interactions with LYS27. 
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